Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnosed With Metastatic Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04928820
What this trial is testing

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
Jonsson Comprehensive Cancer Center 22
Large-scale testing (Phase 3)Looking for participantsNCT03495427
What this trial is testing

PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores

Who this might be right for
Prostate CancerRecurrent Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07466498
What this trial is testing

Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

Who this might be right for
Castration-Sensitive Prostate AdenocarcinomaMetastatic Castration-Sensitive Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Fred Hutchinson Cancer Center 60
Not applicableLooking for participantsNCT07406282
What this trial is testing

Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

Who this might be right for
Prostatic NeoplasmsMetastatic Hormone-Sensitive Prostate Cancer
Bayer 1,400
Large-scale testing (Phase 3)UnknownNCT00363285
What this trial is testing

Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
St. Bartholomew's Hospital 900
Testing effectiveness (Phase 2)Looking for participantsNCT06992232
What this trial is testing

Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC

Who this might be right for
Prostate Cancer Metastatic Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262154
What this trial is testing

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT03763253
What this trial is testing

Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms

Who this might be right for
Prostate CancerMetastatic Prostate Cancer
Imperial College London 433
Testing effectiveness (Phase 2)Ended earlyNCT02582749
What this trial is testing

Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases

Who this might be right for
Prostate CancerBone MetastasesProstate Neoplasms
Ajjai Alva, MD 16
Large-scale testing (Phase 3)Looking for participantsNCT07831824
What this trial is testing

Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])

Who this might be right for
Prostate Cancer
Lantheus Medical Imaging 408
Not applicableEnded earlyNCT00918645
What this trial is testing

Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis

Who this might be right for
Metastatic CancerProstate Cancer
University of California, Davis 13
Not applicableNo Longer AvailableNCT04854369
What this trial is testing

68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly)

Who this might be right for
Prostatic NeoplasmsProstatic Neoplasms, Castration-Resistant
Tulane University
Not applicableUnknownNCT05154474
What this trial is testing

Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy

Who this might be right for
Metastatic CancerCancer, BreastCancer Colon+12 more
Weprom 150
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Not applicableStudy completedNCT03034070
What this trial is testing

Whole-Body 3D T1-weighted MR Imaging Anatomical Sequences: GE mDixon vs FSE (View) Approaches in Prostate Cancer.

Who this might be right for
Prostate AdenocarcinomaMetastasis
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 30
Large-scale testing (Phase 3)Study completedNCT02981368
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 385
Very early researchUnknownNCT06462495
What this trial is testing

Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Who this might be right for
Prostate CancerPET/CT
Anhui Provincial Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00666666
What this trial is testing

R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage IV Prostate Cancer
National Cancer Institute (NCI) 55
Not applicableActive Not RecruitingNCT07721532
What this trial is testing

Observing the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate Cancer

Who this might be right for
Diagnosed With Metastatic Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 3,000
Not applicableStudy completedNCT04318028
What this trial is testing

An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer

Who this might be right for
Non-Metastatic Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+7 more
University of Southern California 20
Next Page